atrify GDSN-Nutzergruppe – Positionspapier vom März 2023
Die Hersteller von Medizinprodukten ermutigen die Anbieter von EDI-Lösungen, die Effizienz von EDI zu erhöhen, indem sie das GDSN, das weltweit verwendete GS1-Standardverfahren für den Austausch von Produktinformationen, nutzen. Das GDSN wird die Datenqualität im Vergleich zum derzeitigen Verfahren, das auf individuellen Prozessen wie Excel-Tabellen basiert, erheblich verbessern.
GDSN ist ein robustes und bewährtes Verfahren, das seit 20 Jahren besteht und dafür sorgt, dass Empfänger wie EDI-Anbieter qualitativ hochwertige, konsistente Daten direkt von den Herstellern erhalten. Viele Datenempfänger wie Krankenhäuser oder Einkaufsgemeinschaften auf der ganzen Welt haben das GDSN, das derzeit über 5 Millionen medizinische Geräte und pharmazeutische Produkte weltweit enthält, erfolgreich implementiert, und es werden regelmäßig neue Empfänger aufgenommen. Die atrify-Gemeinschaft ist bereit, mit den EDI-Anbietern zusammenzuarbeiten, um eine reibungslose Implementierung des GDSN durch diese sicherzustellen.
1) Vorteile für EDI-Lösungsanbieter:
- EFFIZIENZ DER DATENVERWALTUNG:
- Reibungslosere EDI-Prozesse und damit effizientere Prozesse in der Lieferkette (Bestellungen, Rechnungen, ASNs…) durch eine höhere Qualität der mit den EDI-Anbietern ausgetauschten Daten. Ausweitung der Anzahl genauer elektronischer Produktattribute zur Unterstützung der EDI-Nachrichtenverarbeitung und der Portalpräsentation. Einhaltung von Industriestandards (keine Lokalisierungen und Anpassungen).
- KOSTENREDUZIERUNG:
- Verringerung des Verwaltungsaufwands, der durch die schlechte Qualität der durch proprietäre Prozesse erhaltenen Daten entsteht (z. B. Verfolgung der Hersteller zur Korrektur/Vervollständigung fehlender Daten)
- Auswirkungen der Datenqualität auf die EDI-Transaktionen.
- Gemeinsame Nutzung gleicher, unveränderter Attributdaten entlang der Prozesskette (Roaming Use)
2) Einhergehende Vorteile für die Hersteller:
- KOSTENREDUKTION und EFFIZIENZ DES DATENMANAGEMENTS:
- Reibungslosere EDI-Prozesse
- Abschaffung manueller Arbeiten ohne Mehrwert (regelmäßiges oder ad-hoc Ausfüllen von proprietären Excel-Tabellen des EDI-Anbieters mit Stammdaten, die bereits verfügbar sind und von den Herstellern im GDSN geteilt werden)
- Erhöhung der Datenqualität, Sicherstellung der Konsistenz der von den Herstellern gemeinsam genutzten Daten
- Unterstützung von Kundenprozessen, Erhalt besserer Bestelldaten von Kunden.
3) Verbesserung der Patientensicherheit
-
- Weniger Zeitaufwand für die Pflege von Produktdaten
- verbesserter Bestellprozess und Lagerverwaltung, wodurch Engpässe verringert werden
- Bereitstellung des richtigen Produkts zum richtigen Zeitpunkt und am richtigen Ort (“erhalten, was bestellt werden sollte”)
4) Prozess:
-
- EDI-Anbieter müssen mit den Herstellern abklären, welche GDSN-Daten sie empfangen müssen (Datenmodellanalyse)
- EDI-Anbieter abonnieren eine GDSN-Lizenz, um Zugang zum Netzwerk zu erhalten und Produktdaten von allen GDSN-fähigen Herstellern für ihre Länder zu erhalten
- Die Hersteller beginnen mit der Veröffentlichung dieser Daten an die EDI-Anbieter
Beispiele von Mitgliedsunternehmen der atrify GDSN User Group, die zu diesem Dokument beigetragen haben:
| Alfresa | Arthesys | Asahi | B Braun |
Bauernfeind |
bioMérieux |
| BioRad | Biotech Dental | Boehringer | ConvaTec | Cook Medical | Essity |
| Fujifilm | Haier BioMedical | Heidelberg Engineering | Andreas Hettich | Implantcast | Joimax |
| Kuraray | Laerdal | Mahe Medical | Mani | Marienfeld Superior | Mediplus |
| Medtronic | Merete | MID SAS | Mölnlycke | Olympus | Paul Hartmann |
| Peters Surgical | Philips | Queisser Pharma | Richard Wolf | Roche | Sarstedt |
| Shamir | Siemens | Silony | Sonova | CRM Microport | Spiegelberg |
| Terumo | Togo Medikit | Trulife | Ulrich Medical | Uvex | Vitalograph |
| Vygon |
atrify GDSN user group – March 2023 position paper
>Medical device manufacturers encourage EDI solution providers to increase the efficiency of EDI by leveraging the GDSN, which is the GS1 standard process to exchange product information used worldwide. GDSN will substantially increase data quality compared to the current process based on individual processes such as Excel spreadsheets. GDSN is a robust and proven process which has been in existence for 20 years, driving at ensuring that recipients, such as EDI providers, receive high quality, consistent data directly from the manufacturers. Many Data recipients such as Hospitals or Group purchasing organizations across the globe have successfully implemented the GDSN, which currently
holds over 5 million of medical devices and pharmaceutical products worldwide, and new Recipients are getting on-boarded regularly. The atrify community is willing to cooperate with the EDI Providers to ensure a smooth implementation of the GDSN by them.
1) Benefits for EDI solution providers:
- DATA MANAGEMENT EFFICIENCY:
-
- Smoother EDI process and therefore, more efficient Supply chain processes (orders, invoices, ASNs…) through higher quality level of data shared with the EDI providers. Expanding set of accurate electronic product attribute for EDI message processing support and Portal presentation. Adhering to industry (no localizations and customizing.
- COST REDUCTION:
- Suppress administrative work created by the poor quality of data received through proprietary processes (e.g. chasing manufacturers for corrections/completions of missing data)
- Impact of data quality on the EDI transactions.
- Sharing same, unmodified attribute data along the process chain (roaming use)
2) Corresponding Benefits for manufacturers:
- COST REDUCTION and DATA MANAGEMENT EFFICIENCY:
- Smoother EDI processes
- Suppress manual work having no added value (filling-in proprietary Excel spreadsheets of the EDI provider, on a regular or ad-hoc basis, with master data already ready to be available and shared by the manufacturers in the GDSN)
- Increase data quality, ensure consistency of data shared by manufacturers
- Support customer processes, receive better order data from customers
3) Ultimately improving Patient safety
- Less time spent on maintenance of product data
- improved ordering process and warehouse management reducing shortages
- making the right product available when and where needed (“received what was intended to order”)
4) Process:
- EDI providers to confirm with the manufacturers which GDSN data they need to receive (data model analysis)
- EDI providers to subscribe to a GDSN licence to access the network and be able to receive product information from all the GDSN enabled manufacturers for their countries of activity
- Manufacturers to start publishing those data to the EDI Providers
Example of Member companies of the atrify GDSN user group having contributed to this document:
| Alfresa | Arthesys | Asahi | B Braun |
Bauernfeind |
bioMérieux |
| BioRad | Biotech Dental | Boehringer | ConvaTec | Cook Medical | Essity |
| Fujifilm | Haier BioMedical | Heidelberg Engineering | Andreas Hettich | Implantcast | Joimax |
| Kuraray | Laerdal | Mahe Medical | Mani | Marienfeld Superior | Mediplus |
| Medtronic | Merete | MID SAS | Mölnlycke | Olympus | Paul Hartmann |
| Peters Surgical | Philips | Queisser Pharma | Richard Wolf | Roche | Sarstedt |
| Shamir | Siemens | Silony | Sonova | CRM Microport | Spiegelberg |
| Terumo | Togo Medikit | Trulife | Ulrich Medical | Uvex | Vitalograph |
| Vygon |
atrify GDSN user group – March 2023 position paper
Medical device manufacturers encourage EDI solution providers to increase the efficiency of EDI by leveraging the GDSN, which is the GS1 standard process to exchange product information used worldwide. GDSN will substantially increase data quality compared to the current process based on individual processes such as Excel spreadsheets. GDSN is a robust and proven process which has been in existence for 20 years, driving at ensuring that recipients, such as EDI providers, receive high quality, consistent data directly from the manufacturers. Many Data recipients such as Hospitals or Group purchasing organizations across the globe have successfully implemented the GDSN, which currently
holds over 5 million of medical devices and pharmaceutical products worldwide, and new Recipients are getting on-boarded regularly. The atrify community is willing to cooperate with the EDI Providers to ensure a smooth implementation of the GDSN by them.
1) Benefits for EDI solution providers:
- DATA MANAGEMENT EFFICIENCY:
-
- Smoother EDI process and therefore, more efficient Supply chain processes (orders, invoices, ASNs…) through higher quality level of data shared with the EDI providers. Expanding set of accurate electronic product attribute for EDI message processing support and Portal presentation. Adhering to industry (no localizations and customizing.
- COST REDUCTION:
- Suppress administrative work created by the poor quality of data received through proprietary processes (e.g. chasing manufacturers for corrections/completions of missing data)
- Impact of data quality on the EDI transactions.
- Sharing same, unmodified attribute data along the process chain (roaming use)
2) Corresponding Benefits for manufacturers:
- COST REDUCTION and DATA MANAGEMENT EFFICIENCY:
- Smoother EDI processes
- Suppress manual work having no added value (filling-in proprietary Excel spreadsheets of the EDI provider, on a regular or ad-hoc basis, with master data already ready to be available and shared by the manufacturers in the GDSN)
- Increase data quality, ensure consistency of data shared by manufacturers
- Support customer processes, receive better order data from customers
3) Ultimately improving Patient safety
- Less time spent on maintenance of product data
- improved ordering process and warehouse management reducing shortages
- making the right product available when and where needed (“received what was intended to order”)
4) Process:
- EDI providers to confirm with the manufacturers which GDSN data they need to receive (data model analysis)
- EDI providers to subscribe to a GDSN licence to access the network and be able to receive product information from all the GDSN enabled manufacturers for their countries of activity
- Manufacturers to start publishing those data to the EDI Providers
Example of Member companies of the atrify GDSN user group having contributed to this document:
| Alfresa | Arthesys | Asahi | B Braun |
Bauernfeind |
bioMérieux |
| BioRad | Biotech Dental | Boehringer | ConvaTec | Cook Medical | Essity |
| Fujifilm | Haier BioMedical | Heidelberg Engineering | Andreas Hettich | Implantcast | Joimax |
| Kuraray | Laerdal | Mahe Medical | Mani | Marienfeld Superior | Mediplus |
| Medtronic | Merete | MID SAS | Mölnlycke | Olympus | Paul Hartmann |
| Peters Surgical | Philips | Queisser Pharma | Richard Wolf | Roche | Sarstedt |
| Shamir | Siemens | Silony | Sonova | CRM Microport | Spiegelberg |
| Terumo | Togo Medikit | Trulife | Ulrich Medical | Uvex | Vitalograph |
| Vygon |
